High-dose methotrexate in the treatment of osteosarcoma: therapeutic measures against acute intoxication

被引:0
|
作者
Alanon, A. M. [1 ]
Araque, P. [1 ]
Arrazola, T. [1 ]
Peran, L. [1 ]
Fernandez, M. A. [1 ]
Calleja, M. A. [1 ]
Plaza, C. [1 ]
机构
[1] Hosp Univ Virgen De Las Nieves, Serv Pharm, Granada, Spain
关键词
intoxication; Methotrexate;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:464 / 465
页数:2
相关论文
共 50 条
  • [1] High-dose methotrexate in fibroblastic osteosarcoma
    Chowbay, B
    Siong, KK
    ANNALS OF PHARMACOTHERAPY, 2001, 35 (12) : 1669 - 1669
  • [2] Outpatient administration of high-dose methotrexate for osteosarcoma treatment in Brazil
    Macedo, C. R.
    Cappellano, A. M.
    Noguchi, D. T.
    Martinho, A. P.
    Dias, C. G.
    Dias, C. G.
    Malheiros, R. C.
    Dutra, A. H.
    Grings, M.
    Pires, A. L.
    Petrilli, A. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [3] Pharmacogenetic analysis of high-dose methotrexate treatment in paediatric osteosarcoma
    Hegyi, M.
    Csordas, K.
    Eipel, O.
    Csagoly, E.
    Erdelyi, D. J.
    Semsei, A. F.
    Kovacs, G. T.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S353 - S353
  • [4] Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma
    Hegyi, Marta
    Arany, Adam
    Semsei, Agnes F.
    Csordas, Katalin
    Eipel, Oliver
    Gezsi, Andras
    Kutszegi, Nora
    Csoka, Monika
    Muller, Judit
    Erdelyi, Daniel J.
    Antal, Peter
    Szalai, Csaba
    Kovacs, Gabor T.
    ONCOTARGET, 2017, 8 (06) : 9388 - 9398
  • [5] High-dose methotrexate and risk factors for intoxication
    Clarivet, B.
    Martinez, A.
    Vincent, L.
    Vergely, L.
    Hicheri, Y.
    Hillaire-Buys, D.
    Cartron, G.
    Mathieu, O.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 : 44 - 44
  • [6] Neoadjuvant chemotherapy with high-dose methotrexate in osteosarcoma
    Mir, Olivier
    Ropert, Stanislas
    Goldwasser, Francois
    LANCET ONCOLOGY, 2008, 9 (12): : 1198 - 1198
  • [7] Pharmacokinetic Individualization of High-Dose Methotrexate Chemotherapy for the Treatment of Localized Osteosarcoma
    Fujita, Y.
    Nakamura, T.
    Aomori, T.
    Nishiba, H.
    Shinozaki, T.
    Yanagawa, T.
    Takagishi, K.
    Watanabe, H.
    Okada, Y.
    Nakamura, K.
    Horiuchi, R.
    Yamamoto, K.
    JOURNAL OF CHEMOTHERAPY, 2010, 22 (03) : 186 - 190
  • [8] HIGH-DOSE METHOTREXATE TREATMENT AND LIVER-FUNCTION IN PATIENTS WITH OSTEOSARCOMA
    FABBRI, A
    MOTTA, E
    FERRARI, S
    LONGHI, C
    MARCHI, E
    BACCI, G
    FIGUS, E
    MARCHESINI, G
    JOURNAL OF INTERNAL MEDICINE, 1994, 236 (02) : 209 - 214
  • [9] Variability in dose intensity of high-dose methotrexate for nonmetastatic osteosarcoma
    Leavey, PJ
    Mantadakis, E
    Maale, G
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2002, 19 (07) : 483 - 489
  • [10] DOSAGE ADJUSTMENT OF HIGH-DOSE METHOTREXATE IN ADULT OSTEOSARCOMA
    PIGNON, T
    LACARELLE, B
    GUILLET, P
    DUFFAUD, F
    CATALIN, J
    DURAND, A
    FAVRE, R
    BULLETIN DU CANCER, 1994, 81 (11) : 976 - 978